Literature DB >> 12444966

Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.

Karine Steketee1, Cor A Berrevoets, Hendrikus J Dubbink, Paul Doesburg, Remko Hersmus, Albert O Brinkmann, Jan Trapman.   

Abstract

The N-terminal domain (NTD) and the ligand-binding domain (LBD) of the androgen receptor (AR) exhibit a ligand-dependent interaction (N/C interaction). Amino acids 3-36 in the NTD (AR3-36) play a dominant role in this interaction. Previously, it has been shown that a PhixxPhiPhi motif in AR3-36, 23FxxLF27, is essential for LBD interaction. We demonstrate in the current study that AR3-36 can be subdivided into two functionally distinct fragments: AR3-13 and AR16-36. AR3-13 does not directly interact with the AR LBD, but rather contributes to the transactivation function of the AR.NTD-AR.LBD complex. AR16-36, encompassing the 23FxxLF27 motif, is predicted to fold into a long amphipathic alpha-helix. A second PhixxPhiPhi candidate protein interaction motif within the helical structure, 30VREVI34, shows no affinity to the LBD. Within AR16-36, amino acid residues in and flanking the 23FxxLF27 motif are demonstrated to modulate N/C interaction. Substitution of Q24 and N25 by alanine residues enhances N/C interaction. Substitution of amino acids flanking the 23FxxLF27 motif by alanines are inhibitory to LBD interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444966     DOI: 10.1046/j.1432-1033.2002.03276.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 2.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

3.  Ligand-specific dynamics of the androgen receptor at its response element in living cells.

Authors:  Tove I Klokk; Piotr Kurys; Cem Elbi; Akhilesh K Nagaich; Anindya Hendarwanto; Thomas Slagsvold; Ching-Yi Chang; Gordon L Hager; Fahri Saatcioglu
Journal:  Mol Cell Biol       Date:  2006-12-22       Impact factor: 4.272

4.  Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.

Authors:  Suxia Bai; Bin He; Elizabeth M Wilson
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.

Authors:  Dennis J van de Wijngaart; Michel Molier; Scott J Lusher; Remko Hersmus; Guido Jenster; Jan Trapman; Hendrikus J Dubbink
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.

Authors:  Dennis J van de Wijngaart; Hendrikus J Dubbink; Michel Molier; Carola de Vos; Jan Trapman; Guido Jenster
Journal:  Mol Endocrinol       Date:  2009-09-17

7.  Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.

Authors:  John T Minges; Shifeng Su; Gail Grossman; Amanda J Blackwelder; Elena A Pop; James L Mohler; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

Review 8.  Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.

Authors:  Frank Claessens; Sarah Denayer; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Annemie Haelens
Journal:  Nucl Recept Signal       Date:  2008-06-27

9.  New Insights into the Binding Mechanism of Co-regulator BUD31 to AR AF2 Site: Structural Determination and Analysis of the Mutation Effect.

Authors:  Tianqing Song; Jiazhong Li
Journal:  Curr Comput Aided Drug Des       Date:  2020       Impact factor: 1.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.